Bleakley Financial Group, LLC Dr Reddys Laboratories LTD Transaction History
Bleakley Financial Group, LLC
- $4.31 Trillion
- Q3 2025
A detailed history of Bleakley Financial Group, LLC transactions in Dr Reddys Laboratories LTD stock. As of the latest transaction made, Bleakley Financial Group, LLC holds 15,185 shares of RDY stock, worth $211,678. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,185
Previous 14,866
2.15%
Holding current value
$211,678
Previous $223 Million
4.99%
% of portfolio
0.0%
Previous 0.01%
Shares
2 transactions
Others Institutions Holding RDY
# of Institutions
250Shares Held
94.4MCall Options Held
0Put Options Held
0-
Robeco Institutional Asset Management B.V.13.1MShares$182 Million0.27% of portfolio
-
Royal Bank Of Canada Toronto, A610.2MShares$142 Million0.02% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny8.78MShares$122 Million0.17% of portfolio
-
Aikya Investment Management LTD London, X06.72MShares$93.6 Million26.28% of portfolio
-
Morgan Stanley New York, NY6.32MShares$88.1 Million0.01% of portfolio
About DR REDDYS LABORATORIES LTD
- Ticker RDY
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 166,028,992
- Market Cap $2.31B
- Description
- Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company worldwide. It operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), Proprietary Products, and Others segments. The company's Global Generics segment manufactures and markets prescription and over-t...